Shopping Cart
- Remove All
Your shopping cart is currently empty
TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $36 | In Stock | |
| 5 mg | $66 | In Stock | |
| 10 mg | $103 | In Stock | |
| 25 mg | $173 | In Stock | |
| 50 mg | $248 | In Stock | |
| 100 mg | $335 | In Stock | |
| 200 mg | $461 | In Stock |
| Description | TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer. |
| Targets&IC50 | JAK2:11.2 μM |
| Molecular Weight | 510.65 |
| Formula | C26H34N6O3S |
| Cas No. | 936091-56-4 |
| Smiles | Cc1cnc(Nc2cccc(CN3CCOCC3)c2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C |
| Relative Density. | 1.27 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: < 1 mg/mL (insoluble or slightly soluble) |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.